Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01670461 · ClinicalTrials.gov registry record · NA

FAmily CEntered (FACE) Advance Care Planning for Teens With Cancer

A NA study, sponsored by Maureen Lyon.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT01670461: Completed NA study, sponsored by Maureen Lyon.

NCT01670461 is a NA study that has completed, run by Maureen Lyon. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01670461, a NA study, has completed, sponsored by Maureen Lyon.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

Advance Care Planning (ACP) prepares patients and their loved ones for future health care decisions, including end-of-life decisions. Yet, the needs of adolescent oncology patients for participation in ACP, despite its priority, is not well studied. Our goal is to test a model of ACP that anticipates these issues, fully empowers the family and adolescent, and keeps the key role of health care professionals central, building on our earlier work. We hypothesized FAmily CEntered (FACE) ACP, would: (1) increase congruence in treatment preferences between adolescents and surrogates; (2) decrease decisional conflict for adolescents; and (3) increase quality of communication compared with controls.

Primary Outcome

Statement of Treatment Preferences expresses values and goals related to future decision making regarding frequently occurring scenarios common to individuals dying of cancer). This instrument will be used to document specific treatment preferences of patients and the surrogate's understanding of what the patient would want. Patients and surrogates choose one of three options, "to continue all treatment and keep fighting," "to stop all treatment to prolong my life," and "don't know." It can also

Interventions

  • BEHAVIORAL FACE
  • BEHAVIORAL Standard of Care (SOC) Control

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2009-01
Est. Completion 2013-06
Phase NA
Maureen Lyon

5 total trials

What the finished NCT01670461 record still lists

NCT01670461 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which FACE is the first listed.

NCT01670461 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01670461 about?

NCT01670461 is a clinical study titled "FAmily CEntered (FACE) Advance Care Planning for Teens With Cancer". Advance Care Planning (ACP) prepares patients and their loved ones for future health care decisions, including end-of-life decisions. Yet, the needs of adolescent oncology patients for participation in ACP, despite its priority, is not well studied. Our goal is to test a model of ACP that anticipate...

What is the current status of trial NCT01670461?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2009-01. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01670461?

The interventions under investigation include: FACE (BEHAVIORAL), Standard of Care (SOC) Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT01670461?

This trial is sponsored by Maureen Lyon, which has 5 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01670461's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01670461, the US trial registry maintained by the National Library of Medicine. NCT01670461 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.